For a stock that had been struggling for significance for much of the past year, this dramatic shift was not merely a rally — ...

Through the first three quarters of 2025, M&A activity overtook the entire 2024 total, according to Endpoints News. Editor and founder John Carroll wrote in October this might be the best time in 15 ...

Wave's bullish start to the week was driven by the encouraging readout of a Phase 1 clinical study of WVE-007, its obesity ...

The biotech's investigational weight loss drug did very well in a clinical trial. This is a white-hot segment of the pharmaceutical market, so it's little wonder investors subsequently pounced on the ...

Actively moving up the value chain toward drug discovery, development and digital therapeutics is key to sustaining the State ...

Scientists have discovered that complex life began evolving much earlier than traditional models suggested. Using an expanded ...

We came across a bullish thesis on Wave Life Sciences Ltd. on Valueinvestorsclub.com by zamperini. In this article, we will ...

Life Sciences ventures face high levels of scientific, clinical and commercial pathway uncertainty, and these uncertainties present many opportunities for entrepreneurial innovation. This course is ...

Join Bisnow’s Chicago Quantum & Life Science Forum - the only event bringing together researchers, entrepreneurs, investors ...

Delaware has seen a 65% increase in new biotechnology companies over the past decade, according to a recent report by the Delaware BioScience Association and the Delaware Prosperity Partnership. This ...

Understand the fundamentals that drive life. Do basic research that leads to medical breakthroughs and improvements in our world. Study the underlying chemistry of organisms and ecosystems. Help ...

The Board on Life Sciences (BLS) was established in 1984 to serve as the focal point for addressing critical, emerging policy and technical issues associated with the life sciences and biotechnology ...